In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies.In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing the companies. Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, Drugstores, Antitrust Laws and Competition Issues, Regulation and Deregulation of Industry, pharmacy benefit managers, United States Politics and Government, CIGNA Corporation, CVS Caremark Corporation, Express Scripts Inc, Federal Trade Commission, UnitedHealth Group Inc, Khan, Lina Read More
